Trade AstraZeneca ^AZN

AstraZeneca (AZN) Gains Approval for Imfinzi in Bladder Cancer Treatment

25,037 Shares in Astrazeneca Plc $AZN Purchased by SBI Okasan Asset Management Co.Ltd. - Stock Observer

Thoroughbred Financial Services LLC Makes New $1.49 Million Investment in AstraZeneca PLC $AZNCF - Stock Observer

CelLBxHealth signs master services agreement with AstraZeneca

AZN Gains FDA Approval for New Bladder Cancer Treatment

Texas Capital Bank Wealth Management Services Inc Acquires Shares of 3,416 Astrazeneca Plc $AZN - Daily Political

What McCormick (MKC)'s Move to Add a Digital and AI Strategist to Its Board Means for Shareholders - Simply Wall St News

AstraZeneca's durvalumab approved in U.S. for NMIBC patients

AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results

AstraZeneca (AZN) Receives FDA Approval for Imfinzi in Bladder Cancer Treatment

AstraZeneca (AZN) Gains FDA Approval for Imfinzi in Bladder Cancer Treatment

AstraZeneca (AZN) Secures U.S. Approval for Imfinzi Combination Therapy

AstraZeneca: Oncology and Rare Disease Data at ASCO 2026

Cary Street Partners Financial LLC Makes New Investment in AstraZeneca PLC $AZNCF - Zolmax

Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy

AZN's Patent Granted in Canada Strengthens Position in Male Infertility Treatment

FDA delays ruling on AstraZeneca drug after negative adcomm vote

William Blair Investment Management LLC Raises Stake in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca falls 7% as Q4 net profit declines 23%; here's a trading strategy for the pharma stock

3,842 Shares in Astrazeneca Plc $AZN Acquired by M3 Wealth Management LLC - Stock Observer

UK Value Opportunities: Serica Energy Among 3 Stocks Priced Below Intrinsic Estimates

Preparing for a time when living to age 120 is commonplace | AfricaPulse.com

Bleakley Financial Group LLC Has $15.34 Million Holdings in Astrazeneca Plc $AZN - Stock Observer

Hantz Financial Services Inc. Buys 39,244 Shares of Astrazeneca Plc $AZN - Stock Observer

Main Street Research LLC Makes New Investment in Astrazeneca Plc $AZN - Stock Observer

GPS Wealth Strategies Group LLC Decreases Stock Holdings in Astrazeneca Plc $AZN - Zolmax

AstraZeneca's Camizestrant: EU Approves Game-Changing Breast Cancer Pill Amid US Concerns, ETPharma

Insider Sell: Mani Sharma Sells Shares of AstraZeneca PLC

FDA Approves AstraZeneca And Daiichi's Datroway For Treating Metastatic Breast Cancer

AstraZeneca (AZN) Gains U.S. Approval for Datroway in Breast Cancer Treatment

AstraZeneca Breast Cancer Drug Recommended for Approval by EU Regulator | Morningstar

AstraZeneca, Daiichi Sankyo's Datroway Gets Approval In US For Treatment Of Breast Cancer

AZN Receives Positive EU Approval Recommendation for Enhertu

Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates | Morningstar

AstraZeneca (AZN) Showcases Promising Clinical Data at ASCO Annual Meeting

AstraZeneca's Camizestrant Receives Positive Opinion from EMA

EU regulator recommends positive opinion of AstraZeneca's experimental breast cancer drug

Vestmark Advisory Solutions Inc. Acquires 93,186 Shares of Astrazeneca Plc $AZN - Stock Observer

Keudell Morrison Wealth Management Buys New Position in Astrazeneca Plc $AZN - Stock Observer

Astrazeneca (NYSE:AZN) Receives "Sell" Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft Reaffirms Sell Rating for Astrazeneca (NYSE:AZN) - Zolmax

Global Retirement Partners LLC Has $9.85 Million Stock Position in Astrazeneca Plc $AZN - Daily Political

25,822 Shares in AstraZeneca PLC $AZNCF Acquired by Burling Wealth Partners LLC - Stock Observer

How VEPPANU Approval Frames Expectations For AstraZeneca's Camizestrant In ESR1 Disease

Compugen Ltd. (NASDAQ:CGEN) Q1 2026 Earnings Call Transcript

Astrazeneca Plc (NYSE:AZN) Receives $205.33 Average Target Price from Analysts - Zolmax

Harvest Portfolios Group Inc. Sells 39,131 Shares of Astrazeneca Plc $AZN

Astrazeneca Plc $AZN Shares Acquired by Envestnet Portfolio Solutions Inc.

Gabelli Funds LLC Cuts Stock Holdings in Astrazeneca Plc $AZN - Stock Observer

Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results

AstraZeneca, Roche join forces to boost AI-based cancer pathology across Asia

Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids

Astrazeneca Plc $AZN Shares Acquired by ProShare Advisors LLC - Stock Observer

Northwestern Mutual Wealth Management Co. Increases Stake in Astrazeneca Plc $AZN - Daily Political

AstraZeneca (AZN) Faces Potential Market Shifts Amid Trump's Prescription Plan

AstraZeneca Wins FDA Approval for $5 Billion Blood Pressure Drug

AstraZeneca (AZN) Receives US Approval for Innovative Hypertension Treatment

AstraZeneca (AZN) Gains Approval for New Hypertension Drug Baxfendy

North American Morning Briefing: Stock Futures Slip Amid Mideast, Inflation Pessimism | Morningstar

Dow Jones Top Company Headlines at 5 AM ET: Anglo American to Sell Australian Steelmaking Coal Assets for Up to $3.875 Billion | AstraZeneca ... | Morningstar

Dow Jones Top Company Headlines at 3 AM ET: Anglo American to Sell Steelmaking Coal Assets to Dhilmar for Up to $3.875 Billion | AstraZeneca ... | Morningstar

AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu

AstraZeneca: FDA Approves Enhertu For Two New Indications

AstraZeneca's New Blood Pressure Drug Baxfendy Approved by FDA, ETPharma

AstraZeneca's blood pressure drug wins US approval

AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer

Sensorion Appoints Fred Chereau as Chief Executive Officer | Morningstar

New hypertension option as Astrazeneca's Baxfendy wins FDA nod | BioWorld

Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare | News Express Nigeria

Ghana Hypertension Day Exposes Dangerous Treatment Gap | NewsGhana

Independent Advisor Alliance Sells 3,393 Shares of Astrazeneca Plc $AZN - Zolmax

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 34% One Year Rally?

Astrazeneca (NYSE:AZN) Earns Buy Rating from JPMorgan Chase & Co. - Daily Political

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Breast Cancer Treatment from Daiichi Sankyo, AstraZeneca Approved in U.S. | Morningstar

Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer | Morningstar

AstraZeneca (AZN) Sees Leadership Changes at FDA

Bristol Myers Squibb turns to China's Hengrui to replenish pipeline

ULTOMIRIS Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Expert recommendations for PIK3CA testing in HR+/HER2− locally advanced and metastatic breast cancer

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons

TR/CC CRB Excess Return Today - Live TRCCRB Index - Investing.com CA

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

'Pfizer and AstraZeneca were ABANDONED, yet…': Sen Johnson drops bombshell on COVID vaccine injuries - The Economic Times Video | ET Tv

AZN Shows Promising Results in Phase III Trial for Muscle-Invasive Bladder Cancer

AZN: Promising Phase III Trial Results for Imfinzi in Bladder Cancer Treatment

AstraZeneca's Imfinzi Shows Promising Survival Benefits in Bladder Cancer Trial, ETPharma

JPMorgan Chase & Co. Reiterates Buy Rating for Astrazeneca (NYSE:AZN) - Stock Observer

AstraZeneca Says Imfinzi Combination Improved Survival In Phase III Bladder Cancer Trial

Omeros Corp (OMER) Q1 2026 Earnings Call Highlights: Strong YARTEMLEA Launch and Strategic ...

AI-powered and manual assessment of tumor-infiltrating lymphocytes in early HER2-positive breast cancer in NSABP B-41

Health: AstraZeneca's Imfinzi with pre-surgery drug boosts survival in bladder cancer trial

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction

Innate Pharma Reports First Quarter 2026 Business Update and Financial Results

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk